Xuefeng Yu
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 21
- Diabetes Treatment and Management 15
- Diet, Metabolism, and Disease 11
-
- Lipid metabolism and disorders 15
- Co-authors
- Tingting Du (20 shared papers)Yan Yang (31 shared papers)Shiying Shao (25 shared papers)Muxun Zhang (15 shared papers)Xingxing Sun (10 shared papers)Shujun Zhang (12 shared papers)Kun Dong (11 shared papers)Xinrong Zhou (10 shared papers)
- Journals
- Frontiers in Endocrinology (9 papers)Cardiovascular Diabetology (7 papers)Journal of Diabetes Investigation (6 papers)Diabetes Research and Clinical Practice (5 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xuefeng Yu
123 papers receiving 4.4k citations
Xuefeng Yu's Hit Papers
Peers
Comparison fields: 5 of 134
- Endocrinology, Diabetes and Metabolism 1.6k
- Infectious Diseases 638
- Physiology 848
- Cardiology and Cardiovascular Medicine 664
- Epidemiology 979
Countries citing papers authored by Xuefeng Yu
This map shows the geographic impact of Xuefeng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Yu more than expected).
Fields of papers citing papers by Xuefeng Yu
This network shows the impact of papers produced by Xuefeng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Yu. The network helps show where Xuefeng Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuefeng Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance Hit paper breakdown → | 2014 | 422 |
| 2 | Clinical characteristics and outcomes of patients with severe covid-19 with diabetes Hit paper breakdown → | 2020 | 408 |
| 3 | 2014 | 205 | |
| 4 | 2017 | 194 | |
| 5 | 2020 | 162 | |
| 6 | 2020 | 134 | |
| 7 | 2014 | 114 | |
| 8 | 2013 | 106 | |
| 9 | 2015 | 105 | |
| 10 | 2013 | 103 | |
| 11 | 2012 | 98 | |
| 12 | 2013 | 82 | |
| 13 | 2012 | 82 | |
| 14 | 2020 | 81 | |
| 15 | 2015 | 74 | |
| 16 | Metformin mitigates autoimmune insulitis by inhibiting Th1 and Th17 responses while promoting Treg production. | 2019 | 69 |
| 17 | 2017 | 67 | |
| 18 | 2016 | 67 | |
| 19 | 2013 | 65 | |
| 20 | 2017 | 64 |
About Xuefeng Yu
Xuefeng Yu is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Molecular Biology, Epidemiology and Physiology, having authored 139 papers that have together received 4.5k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Liver Disease Diagnosis and Treatment (20 papers), Diabetes Treatment and Management (15 papers), Lipid metabolism and disorders (15 papers), Diet, Metabolism, and Disease (11 papers), Pancreatic function and diabetes (10 papers), Diet and metabolism studies (10 papers) and Metabolism, Diabetes, and Cancer (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Infectious Diseases (638 citations), Physiology (848 citations), Cardiology and Cardiovascular Medicine (664 citations) and Epidemiology (979 citations). Xuefeng Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Tingting Du, Yan Yang, Shiying Shao, Muxun Zhang, Xingxing Sun, Shujun Zhang, Kun Dong, Xinrong Zhou, Xiaoli Shi and Gang Yuan. Their work appears in journals such as Frontiers in Endocrinology, Cardiovascular Diabetology, Journal of Diabetes Investigation, Diabetes Research and Clinical Practice and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.